MX2017010122A - Composiciones y metodos para determinar el pronostico de cancer de endometrio. - Google Patents
Composiciones y metodos para determinar el pronostico de cancer de endometrio.Info
- Publication number
- MX2017010122A MX2017010122A MX2017010122A MX2017010122A MX2017010122A MX 2017010122 A MX2017010122 A MX 2017010122A MX 2017010122 A MX2017010122 A MX 2017010122A MX 2017010122 A MX2017010122 A MX 2017010122A MX 2017010122 A MX2017010122 A MX 2017010122A
- Authority
- MX
- Mexico
- Prior art keywords
- endometrial cancer
- compositions
- methods
- determining
- cancer prognosis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
La presente invención proporciona métodos y composiciones para determinar el pronóstico en individuos con cáncer, en particular cáncer de endometrio. La presente invención también proporciona métodos para desarrollar y usar modelos predictivos que son útiles para determinar el pronóstico de cáncer de endometrio y otras enfermedades similares. La presente invención además proporciona métodos para determinar el estado de microsatélites usando secuenciación de nueva generación.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562113340P | 2015-02-06 | 2015-02-06 | |
US201562113990P | 2015-02-09 | 2015-02-09 | |
PCT/US2016/016799 WO2016127067A1 (en) | 2015-02-06 | 2016-02-05 | Compositions and methods for determining endometrial cancer prognosis |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2017010122A true MX2017010122A (es) | 2018-06-06 |
Family
ID=56564751
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2017010122A MX2017010122A (es) | 2015-02-06 | 2016-02-05 | Composiciones y metodos para determinar el pronostico de cancer de endometrio. |
MX2021000899A MX2021000899A (es) | 2015-02-06 | 2017-08-04 | Composiciones y metodos para determinar el pronostico de cancer de endometrio. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2021000899A MX2021000899A (es) | 2015-02-06 | 2017-08-04 | Composiciones y metodos para determinar el pronostico de cancer de endometrio. |
Country Status (7)
Country | Link |
---|---|
US (2) | US20180094301A1 (es) |
EP (2) | EP3819389B1 (es) |
CN (2) | CN115094141A (es) |
BR (1) | BR112017016752A2 (es) |
CA (1) | CA2975737A1 (es) |
MX (2) | MX2017010122A (es) |
WO (1) | WO2016127067A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201614474D0 (en) * | 2016-08-24 | 2016-10-05 | Univ Of Newcastle Upon Tyne The | Methods of identifying microsatellite instability |
AU2018254252A1 (en) * | 2017-04-21 | 2019-11-21 | The University Of British Columbia | Stratification and prognosis of cancer |
US10699802B2 (en) | 2017-10-09 | 2020-06-30 | Strata Oncology, Inc. | Microsatellite instability characterization |
CN108814592A (zh) * | 2018-04-24 | 2018-11-16 | 哈尔滨工业大学 | 基于小波能量判定癫痫发作前脑电信号的方法及系统 |
WO2020178400A1 (en) * | 2019-03-06 | 2020-09-10 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Method to diagnose a cmmrd |
CN112037859B (zh) * | 2020-09-02 | 2023-12-19 | 迈杰转化医学研究(苏州)有限公司 | 一种微卫星不稳定性的分析方法和分析装置 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPO573697A0 (en) * | 1997-03-20 | 1997-04-10 | Prince Henry's Institute Of Medical Research | Diagnosis of endometrial cancer |
EP1892306A3 (en) * | 2003-10-06 | 2008-06-11 | Bayer HealthCare AG | Methods and kits for investigating cancer |
WO2006094014A2 (en) * | 2005-02-28 | 2006-09-08 | The Regents Of The University Of California | Methods for diagnosis and treatment of endometrial cancer |
CA2688049A1 (en) * | 2007-05-31 | 2008-12-04 | Dako Denmark A/S | Methods for utilizing esr copy number changes in breast cancer treatments and prognoses |
EP2454388A2 (en) * | 2009-07-17 | 2012-05-23 | Pamela Pollock | Methods and kits used in assessing cancer risk |
WO2013056178A2 (en) * | 2011-10-14 | 2013-04-18 | Foundation Medicine, Inc. | Novel estrogen receptor mutations and uses thereof |
CN103547683A (zh) * | 2012-03-22 | 2014-01-29 | 耶鲁大学 | Kras突变和肿瘤生物学 |
-
2016
- 2016-02-05 CN CN202210786103.XA patent/CN115094141A/zh active Pending
- 2016-02-05 US US15/548,816 patent/US20180094301A1/en not_active Abandoned
- 2016-02-05 WO PCT/US2016/016799 patent/WO2016127067A1/en active Application Filing
- 2016-02-05 MX MX2017010122A patent/MX2017010122A/es unknown
- 2016-02-05 CN CN201680020371.3A patent/CN107532208B/zh active Active
- 2016-02-05 CA CA2975737A patent/CA2975737A1/en active Pending
- 2016-02-05 BR BR112017016752A patent/BR112017016752A2/pt not_active Application Discontinuation
- 2016-02-05 EP EP20200749.8A patent/EP3819389B1/en active Active
- 2016-02-05 EP EP16747343.8A patent/EP3253891B1/en active Active
-
2017
- 2017-08-04 MX MX2021000899A patent/MX2021000899A/es unknown
-
2023
- 2023-02-21 US US18/112,116 patent/US20230193358A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
MX2021000899A (es) | 2021-03-31 |
US20230193358A1 (en) | 2023-06-22 |
CN115094141A (zh) | 2022-09-23 |
CA2975737A1 (en) | 2016-08-11 |
BR112017016752A2 (pt) | 2018-04-10 |
CN107532208B (zh) | 2022-07-05 |
WO2016127067A1 (en) | 2016-08-11 |
US20180094301A1 (en) | 2018-04-05 |
CN107532208A (zh) | 2018-01-02 |
EP3253891B1 (en) | 2020-11-11 |
EP3253891A1 (en) | 2017-12-13 |
EP3819389A1 (en) | 2021-05-12 |
EP3253891A4 (en) | 2018-09-19 |
EP3819389B1 (en) | 2024-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021000899A (es) | Composiciones y metodos para determinar el pronostico de cancer de endometrio. | |
PH12018502225A1 (en) | Anti-il-33 antibodies, compositions, methods and uses thereof | |
MX2020009649A (es) | Anticuerpos monoclonales contra bcma. | |
PH12017500861A1 (en) | Anti-interleukin-33 antibodies and uses thereof | |
MX2017003478A (es) | Anticuerpos anti-fgfr2/3 y metodos para su uso. | |
MX2017008421A (es) | Métodos terapéuticos, diagnósticos y pronósticos para el cáncer de vejiga. | |
MX2022010623A (es) | Terapias de combinacion que comprenden un receptor quimerico de antigeno cd19 para el cancer. | |
LT3368688T (lt) | Kompozicijos ir būdai, skirti modifikuotų citozinų nustatymui sekvenavimu | |
MX2019007021A (es) | Anticuerpos il-11ra. | |
BR112016008541A2 (pt) | composições úteis para tratar distúrbios relacionados a kit | |
SG10201900455YA (en) | Bcma chimeric antigen receptors | |
MX2019015159A (es) | Composiciones, metodos y usos para asistir en el diagnostico, pronostico y tratamiento de la fibrosis pulmonar idiopatica. | |
MX2017010836A (es) | Panel biomarcador para la deteccion de cancer. | |
MX2020010947A (es) | Metodos de tratamiento de enfermedad de alzheimer. | |
MY176855A (en) | Anti-jagged1 antibodies and methods of use | |
SG10201808835QA (en) | Anti-siglec-8 antibodies and methods of use thereof | |
MX2022001085A (es) | Anticuerpos anti-c1s humanizados y metodos para usarlos. | |
GB2540702A (en) | Nucleic acid processing of a nucleic acid fragment with a triazole linkage | |
MY183189A (en) | Non-human animals having a humanized a proliferation-inducing ligand gene | |
PE20160192A1 (es) | Composiciones y metodo para tratar condiciones asociadas con el complemento | |
MX2016009590A (es) | Composiciones de apilimod y métodos para usar las mismas. | |
NZ738875A (en) | Motile sperm domain containing protein 2 and cancer | |
EP3511422A3 (en) | Methods and compositions for diagnosing, prognosing, and treating endometriosis | |
MX2018010536A (es) | Metodos y composiciones para deteccion y diagnostico de enfermedades renales y enfermedades periodontales. | |
PH12017502277A1 (en) | Multi-specific binding proteins |